Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral leishmaniasis

This publication has 28 references indexed in Scilit:

• The effects of rhGM-CSF on macrophage function
  European Journal Of Cancer, 1993
• Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
  New England Journal of Medicine, 1992
• Interleukin-4 Inhibits Human Macrophage Activation by Tumor Necrosis Factor, Granulocyte-Monocyte Colony-Stimulating Factor, and Interleukin-3 for Antileishmanial Activity and Oxidative Burst Capacity
  The Journal of Infectious Diseases, 1992
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
  The Journal of Experimental Medicine, 1991
• Granulocyte-Macrophage and Macrophage Colony-Stimulating Factors Activate Intramacrophage Killing of Leishmania mexicana amazonensis
  The Journal of Infectious Diseases, 1990
• Granulocyte-Macrophage Colony-Stimulating Factor Augments Human Monocyte Fungicidal Activity for Candida albicans
  The Journal of Infectious Diseases, 1990
• Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon Gamma
  New England Journal of Medicine, 1990
• Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma.
  The Journal of Experimental Medicine, 1987
• Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages.
  The Journal of Experimental Medicine, 1987
• Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.
  Journal of Clinical Investigation, 1985